Cedars-Sinai Giving More Than $2M to Help Those Affected by COVID-19

Newswise — LOS ANGELES (March 27, 2020) -- Even in the best of times, hundreds of thousands of Angelenos struggle to pay rent, put dinner on the table and take care of their health needs. Now, with COVID-19 (coronavirus) spreading across the Los Angeles region, Cedars-Sinai is stepping up assistance for populations that are vulnerable to the health and economic impacts of the virus.

Cedars-Sinai is contributing more than $2 million to programs that provide housing, food assistance and access to healthcare for those in need during this challenging time. The immediate funding infusion comes on top of the $15 million Cedars-Sinai committed last year to support safety-net organizations and the communities they serve.

"In this time of crisis, while our doctors, nurses and healthcare partners work around the clock to care for our patients, we are also reaching out to the surrounding Los Angeles community to help alleviate suffering among our most vulnerable," said Thomas M. Priselac, president and CEO of Cedars-Sinai.

Cedars-Sinai is giving $850,000 in grants to support housing stability organizations, food access programs and food banks that serve low-income, homebound seniors, people experiencing homelessness and other groups in need.

Among the groups receiving grants is Project Angel Food, which will receive $150,000 to fund shelf-stable emergency food packages to their clients. 

“Project Angel Food has continued to feed our 1,600 clients uninterrupted, and it’s only because of generous partners like Cedars-Sinai," said Richard Richard Ayoub, Executive Director of Project Angel Food." We have incurred extra costs by sending more shelf-stable and medically tailored meals to our clients and hired temporary chefs and more drivers. With no near-end in sight of this pandemic, the funding will help us weather through these difficult times and keep us operating as an essential service feeding those in need.”

Other grantees include:

· Brilliant Corners, a nonprofit that creates housing solutions for people experiencing homelessness in partnership with government, healthcare, service providers, landlords and developers. Brilliant Corners will receive $125,000 to be used in partnership with the Los Angeles County Department of Health Services to help mitigate the impact of COVID-19 on the homeless population.

· United Way of Greater Los Angeles will receive $100,000 in support of its Pandemic Relief Fund.

· The Mayor's Fund for L.A. will receive $125,000 for emergency food assistance to people experiencing homelessness in emergency shelters and to seniors through the city Department of Aging.

· Jewish Free Loan Association will receive $250,000 to more easily provide free loans to those facing housing insecurity by supporting the development of an emergency loan guarantor fund.

Additionally, Cedars-Sinai is giving $1 million to the Community Clinic Association of Los Angeles County to help community health centers serve patients safely in this challenging time. The grant will drive clinics to launch or expand telehealth programs that are critical for populations that traditionally lack comprehensive access to healthcare services. Community clinics will partner with telehealth experts to serve an increasing number of patients through new virtual technologies.

Cedars-Sinai has worked closely with statewide and local funders as well as our community partners to determine the highest priorities at this time. The collaboration is a reflection of Cedars-Sinai's deep ties to the Los Angeles community and its history of assisting social service agencies, schools, community clinics, senior centers and other organizations that serve vulnerable populations.

"Los Angeles is in our DNA," Priselac said. "That is why we stand ready to do our part to serve the community in this time of need and going forward."

Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573